Lipoprotein(a) lowering trial flop prompts scientific review
Following the failure of a major clinical trial targeting lipoprotein(a) levels, scientists are evaluating the implications for cardiovascular risk therapi
Following the failure of a major clinical trial targeting lipoprotein(a) levels, scientists are evaluating the implications for cardiovascular risk therapi